Consistent with the previous report, the prevalence of RET fusion in thyroid cancer is 3.11% (7/225), while the occurrence of NTRK3 fusion in thyroid cancer is infrequent, with a frequency of 0.95% (2/225) in our study. This evidence concerns the gene NTRK3 and thyroid gland carcinoma.